PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Metsä Board Oyj (METSA.HE)
5.580.04 (-0.71%)
5.38 - 5.60
4.95 - 8.28
2.3K / 2.4K (Avg.)
-279.00 | -0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-7.34%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-27.70%
Negative gross profit growth while UPM.HE is at 225.56%. Joel Greenblatt would examine cost competitiveness or demand decline.
-44.39%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-44.39%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-35.91%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-36.36%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-36.36%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
-0.28%
Share reduction while UPM.HE is at 0.00%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.43%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
No Data
No Data available this quarter, please select a different quarter.
5.72%
OCF growth under 50% of UPM.HE's 884.08%. Michael Burry might suspect questionable revenue recognition or rising costs.
-152.97%
Negative FCF growth while UPM.HE is at 307.69%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
2.28%
10Y revenue/share CAGR under 50% of UPM.HE's 20.31%. Michael Burry would suspect a lasting competitive disadvantage.
33.94%
5Y revenue/share CAGR 1.25-1.5x UPM.HE's 25.67%. Bruce Berkowitz would verify if cost efficiency or pricing power supports this advantage.
14.59%
3Y revenue/share CAGR under 50% of UPM.HE's 32.04%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
293.42%
10Y OCF/share CAGR at 75-90% of UPM.HE's 341.79%. Bill Ackman would demand strategic changes to close the gap in long-term cash generation.
-33.32%
Negative 5Y OCF/share CAGR while UPM.HE is at 287.22%. Joel Greenblatt would question the firm’s operational model or cost structure.
-28.40%
Negative 3Y OCF/share CAGR while UPM.HE stands at 166.67%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
63.39%
Below 50% of UPM.HE's 132.96%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
80.25%
5Y net income/share CAGR at 75-90% of UPM.HE's 104.94%. Bill Ackman would advocate improvements to match competitor’s profit expansion.
324.81%
3Y net income/share CAGR above 1.5x UPM.HE's 87.92%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
109.80%
10Y equity/share CAGR in line with UPM.HE's 108.91%. Walter Schloss might see both benefiting from stable profitability and moderate payout ratios over the decade.
79.73%
5Y equity/share CAGR above 1.5x UPM.HE's 44.36%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
42.21%
3Y equity/share CAGR above 1.5x UPM.HE's 24.25%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-20.44%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
-1.38%
Inventory is declining while UPM.HE stands at 3.11%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
2.21%
Positive asset growth while UPM.HE is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
6.24%
1.25-1.5x UPM.HE's 4.71%. Bruce Berkowitz sees if the firm's capital management strategies surpass the competitor's approach.
-2.52%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
33.58%
SG&A growth of 33.58% while UPM.HE is zero. Bruce Berkowitz sees more spend on admin or marketing, expecting stronger top-line in return.